Gogia Capital (531600)
TurnaroundScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹81.7 |
| Market Cap | ₹51.64 Cr |
| P/E Ratio | 0 |
| ROCE | -16.07% |
| ROE | -9.86% |
| Dividend Yield | 0% |
| Profit Growth | 0% |
| Debt/Equity | — |
| Sales Growth | 0% |
| 52-Week Range | ₹52.57 — ₹100.25 |
| Sector | Capital Markets |
| Book Value | ₹48.48 |
Strengths
- Reported book value of ₹48.48 per share provides some tangible asset backing.
- Market capitalisation of ₹52 Cr is small enough that a targeted operational overhaul could, in theory, move the needle.
- Latest quarterly net loss of ₹1 Cr is small in absolute terms, not a steep cash-burn emergency based on reported data.
- No dividend payout means cash is not being drained for payouts while the business struggles.
Concerns
- Negative ROE of -9.86% and ROCE of -16.07% indicate clear value destruction on existing equity.
- P/B of 1.69 means the market is asking for a premium to book value for a company with no earnings.
- Piotroski F-score of 3/9 and essentially nil quarterly sales point to weak financial health and a lack of operating activity.
- No dividend and zero growth figures provide no compensation or growth anchor for holding the stock.
AI Analysis
Let me be plain: Gogia Capital does not meet the test I would apply to any investment. It is a stockbroking firm, a business I can understand, but understanding does not mean liking what I see. The latest quarter shows sales of essentially ₹0 Cr and a net loss of ₹1 Cr. Annualise that, and you get a business earning a negative return on equity. Indeed, ROE is -9.86% and ROCE is -16.07%. The book value is ₹48.48 per share, but at ₹81.70 the market is asking me to pay 1.69 times book for a machine that is destroying value. A P/E of 0.00 is not 'cheap'; it is meaningless because there are no earnings. The Piotroski F-score of 3 out of 9 tells me the underlying financial condition is weak. There is no dividend yield, so I am not even paid to wait. Broking is a competitive, commoditised business with no obvious moat, and with zero sales growth and zero profit growth on the record, there is no trajectory to anchor a valuation. The 52-week range of ₹52.57 to ₹101.38 only reminds me that prices move; it does not tell me this is a bargain. I would rather let this small-cap, ₹52 Cr market-cap stock pass me by. If the company can cut losses, restart meaningful broking revenue, and show a reasonable return on its ₹48.48 book value, then I might look again. But buying a loss-making enterprise above book value, with no earnings and a low F-score, is speculation, not value investing. There is no margin of safety.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer